Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

DC populations incubated with rAd5, rAd28, rAd35, TLR7/8-ligand, or unexposed


ABSTRACT: Recombinant adenovirus vectors (rAds) are being investigated as vaccine delivery vehicles in pre-clinical and clinical studies. rAds constructed from different serotypes differ in receptor usage, tropism, and ability to activate cells, aspects of which likely contribute to their different immunogenicity profiles. Here, we compared the infectivity and cell stimulatory capacity of rAds of serotype 5 (rAd5), 28 (rAd28) and 35 (rAd35) in association with their immunogenicity. We found that rAd28 and rAd35 infected, and led to the in vitro maturation and activation of both human and mouse dendritic cells (DCs) more efficiently than did rAd5. In stark contrast to rAd5, rAd28 and rAd35 induced production of interferon-alpha (IFNM-NM-1) and stimulated interferon-related intracellular pathways. However, the in vivo immunogenicity of rAd28 and rAd35 was significantly lower than that of rAd5. Deletion of IFNM-NM-1 signaling during vaccination with rAd28 and rAd35 vectors increased the magnitude of the insert-specific T-cell response to levels induced by vaccination with rAd5 vector. The negative impact of IFNM-NM-1 signaling on the magnitude of the T cell response could be overcome by increasing the vaccine dose, which was also associated with greater polyfunctionality and a more favorable long-term memory phenotype of the CD8 T cell response in the presence of IFNM-NM-1 signaling. Taken together, our results demonstrate that rAd-induced IFNM-NM-1 production has multiple effects on T cell immunogenicity, the understanding of which should be considered in the design of rAd vaccine vectors. FACSAria-purified DC populations were incubated with rAd5, rAd28, rAd35, TLR7/8-ligand, or unexposed, for 24 hours. RNA samples from incubated myeloid DCs (mDCs; n=5 for Ad5, Ad35 and mock; n=4 for Ad28 and TLR7/8-ligand) and plasmacytoid DCs (pDCs; n=5 for Ad28; n=4 for mock; n=3 for Ad35 and TLR7/8-ligand; n=2 for Ad5) were prepared using the Illumina BeadStation assay and hybridized to Illumina RefSeq-8 V3 BeadChips.

ORGANISM(S): Homo sapiens

SUBMITTER: Peter Wilkinson 

PROVIDER: E-GEOD-37128 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicity.

Johnson Matthew J MJ   Petrovas Constantinos C   Yamamoto Takuya T   Lindsay Ross W B RW   Loré Karin K   Gall Jason G D JG   Gostick Emma E   Lefebvre François F   Cameron Mark J MJ   Price David A DA   Haddad Elias E   Sekaly Rafick-Pierre RP   Seder Robert A RA   Koup Richard A RA  

Journal of immunology (Baltimore, Md. : 1950) 20120514 12


Recombinant adenovirus (rAd) vectors are being investigated as vaccine delivery vehicles in preclinical and clinical studies. rAds constructed from different serotypes differ in receptor usage, tropism, and ability to activate cells, aspects of which likely contribute to their different immunogenicity profiles. In this study, we compared the infectivity and cell stimulatory capacity of recombinant adenovirus serotype 5 (rAd5), recombinant adenovirus serotype 28 (rAd28), and recombinant adenoviru  ...[more]

Similar Datasets

2012-07-11 | GSE37128 | GEO
2014-12-30 | GSE64548 | GEO
2016-06-01 | GSE73118 | GEO
2016-06-01 | E-GEOD-73118 | biostudies-arrayexpress
2012-11-20 | GSE22768 | GEO
2012-11-20 | E-GEOD-22768 | biostudies-arrayexpress
2017-09-27 | GSE103204 | GEO
2013-12-15 | E-GEOD-52081 | biostudies-arrayexpress
2015-02-13 | E-MTAB-3115 | biostudies-arrayexpress
2012-11-20 | E-GEOD-22822 | biostudies-arrayexpress